T 1435/20 (Paroxysmal nocturnal hemoglobinuria / ALEXION PHARMACEUTICALS) of 21.09.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T143520.20230921
- Date of decision
- 21 September 2023
- Case number
- T 1435/20
- Petition for review of
- -
- Application number
- 16172335.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
- Applicant name
- Alexion Pharmaceuticals, Inc.
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 76(1)European Patent Convention Art 83European Patent Convention Art 84European Patent Convention R 139Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Admittance (no) - Auxiliary requests 1, 2A, 6, 7A and 9 to 17
Added subject-matter (yes) - Main request and auxiliary requests 3 and 5
Clarity (no) - Auxiliary requests 2 and 7
Sufficiency of disclosure (no)
Sufficiency of disclosure - Auxiliary requests 4 and 8 - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.